Skip to main content

Advertisement

Table 1 Demographical and clinical characteristics of the study participants

From: Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)

Characteristics Classification Value
Gender female, male, n (%) 25 (56.8), 19 (43.2)
Age in years mean (SD) 57.3 (± 15.3)
Type of onset spinal, bulbar, n (%) 42 (95.5), 2 (4.5)
Disease duration (months) mean (SD) 58.4 (± 45)
ALS Functional Rating Scale revised mean (SD) 23.0 (± 9.2)
Presence of cognitive impairment n (%) 3 (6.8)
  1. n Number of patients; SD standard deviation